Galeon is a pioneering French company at the forefront of integrating blockchain technology and artificial intelligence (AI) into the healthcare sector. Established in 2016, Galeon aims to revolutionize medical data management by connecting hospitals, patients, and researchers through a decentralized ecosystem. Their mission is to enhance patient care, facilitate medical research, and democratize access to healthcare innovations.

Tokenomics of $GALEON

The $GALEON token serves as the cornerstone of Galeon's ecosystem, enabling value distribution among patients, caregivers, hospitals, and investors. The token's allocation is designed to ensure equitable sharing of benefits:

  • 50% allocated to patients and token holders through the Galeon DAO fund.
  • 40% designated for hospitals participating in research.
  • 5% allocated to the Galeon company.
  • 5% reinvested in the $GALEON token through a buyback and burn mechanism.

This structure incentivizes active participation and long-term commitment from all stakeholders, fostering a sustainable and collaborative environment for medical research and innovation.

Underlying Technology

Galeon's platform is built upon a trifecta of advanced technologies:

  1. Blockchain Integration: By utilizing blockchain, Galeon ensures secure, transparent, and tamper-proof management of medical data, aligning all stakeholders and safeguarding patient trust.
  2. Artificial Intelligence: Galeon's intelligent Electronic Health Record (EHR) system secures and hyper-structures anonymized health data, enabling the decentralized training of medical AI algorithms while preserving patient privacy.
  3. Decentralized Science (DeSci): Galeon is part of the DeSci movement, unleashing the power of AI and blockchain on health data to decentralize science and facilitate access to data for research purposes.

Market Status of $GALEON

As of December 23, 2024, the $GALEON token is trading at approximately $0.03387, with a market capitalization of around $24.34 million. The token has experienced significant growth over the past year, reflecting increasing investor confidence and interest in blockchain-based healthcare solutions.

Investor Information

Galeon has garnered substantial support from the investment community, with over 50,000 investors contributing to its mission of transforming healthcare. The company is registered by the French Financial Markets Authority (AMF, number E2023-098) to provide secure digital asset services, ensuring regulatory compliance and investor protection.

Development Status

In November 2024, Galeon unveiled its new platform, Atlantis, in beta version accessible through a waitlist. Atlantis is a rich, original, and immersive ecosystem that allows all members of the Galeon community, the 'Pioneers,' to come together and promote a decentralized and community-based approach to medicine. The platform is designed to be gamified, simple, and accessible for everyone, creating a bridge between Web2 and Web3.

Technological Innovation and Potential

Galeon's integration of blockchain and AI positions it at the forefront of technological innovation in healthcare. By enabling secure, decentralized sharing and analysis of medical data, Galeon facilitates personalized, data-driven medical care and research. The platform's collaborative network breaks down silos, enhancing knowledge sharing among healthcare providers and improving patient outcomes. Galeon's approach exemplifies the potential of technology to drive sustainable and patient-centric advancements in medicine.

References